{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:24:55Z","timestamp":1791300295805,"version":"4.1.0"},"reference-count":70,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/mco.2014.397","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T09:19:39Z","timestamp":1408526379000},"page":"909-916","source":"Crossref","is-referenced-by-count":94,"title":["Features of ovarian cancer in Lynch syndrome (Review)"],"prefix":"10.3892","volume":"2","author":[{"given":"KANAKO","family":"NAKAMURA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOUJI","family":"BANNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEGUMI","family":"YANOKURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIHO","family":"IIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASATAKA","family":"ADACHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENTA","family":"MASUDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARISA","family":"UEKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUSUKE","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"NOMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIRA","family":"HIRASAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EIICHIRO","family":"TOMINAGA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAISUKE","family":"AOKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,20]]},"reference":[{"key":"key20180107151056_b1-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0032-1313780","article-title":"Endometrial and ovarian cancer in lynch syndrome","volume":"25","author":"Crispens","year":"2012","journal-title":"Clin Colon Rectal Surg"},{"key":"key20180107151056_b2-mco-02-06-0909","first-page":"126","article-title":"Ovarian cancer screening","volume":"36","author":"Neesham","year":"2007","journal-title":"Aust Fam Physician"},{"key":"key20180107151056_b3-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/9781420052886-3","article-title":"Clinical relevance of hereditary endometrial cancer","volume-title":"Hereditary gynecologic cancer: risk, prevention, and management","author":"Lu","year":"2008","edition":"1st edition"},{"key":"key20180107151056_b4-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","article-title":"Hereditary ovarian cancer: a clinicopathological study","volume":"11","author":"Bewtra","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"key20180107151056_b5-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"key20180107151056_b6-mco-02-06-0909","first-page":"2030","article-title":"Structure and function of the components of the human DNA mismatch repair system","volume":"119","author":"Jascur","year":"2006","journal-title":"lnt J Cancer"},{"key":"key20180107151056_b7-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.34.1.359","article-title":"DNA mismatch repair and genetic instability","volume":"34","author":"Harfe","year":"2000","journal-title":"Annu Rev Genet"},{"key":"key20180107151056_b8-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/humu.21446","article-title":"Recurrence and variability of germline EPCAM deletions in Lynch syndrome","volume":"32","author":"Kuiper","year":"2011","journal-title":"Hum Mutat"},{"key":"key20180107151056_b9-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key20180107151056_b10-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA mismatch repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107151056_b11-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23508","article-title":"The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome","volume":"123","author":"Watson","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180107151056_b12-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","article-title":"Risks of less common cancers in proven mutation carriers with lynch syndrome","volume":"30","author":"Engel","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107151056_b13-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2011.02.010","article-title":"Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors","volume":"121","author":"Ketabi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107151056_b14-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"key20180107151056_b15-mco-02-06-0909","first-page":"421","article-title":"Gynecological malignancy as a \u2018sentinel cancer\u2019 for women with HNPCC","volume":"92","author":"Lu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180107151056_b16-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2001.19.20.4074","article-title":"MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families","volume":"19","author":"Vasen","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180107151056_b17-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1399-0004.2005.00537.x","article-title":"Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome","volume":"68","author":"Cederquist","year":"2005","journal-title":"Clin Genet"},{"key":"key20180107151056_b18-mco-02-06-0909","first-page":"4371","article-title":"Application of the National Cancer Institute International criteria for determination of microsatellite instability in ovarian cancer","volume":"61","author":"Sood","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107151056_b19-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/1097-0142(20011201)92:11<2829::AID-CNCR10094>3.0.CO;2-3","article-title":"Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors","volume":"92","author":"Gras","year":"2001","journal-title":"Cancer"},{"key":"key20180107151056_b20-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.humpath.2003.12.009","article-title":"Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma","volume":"35","author":"Cai","year":"2004","journal-title":"Hum Pathol"},{"key":"key20180107151056_b21-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/modpathol.3800672","article-title":"Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma","volume":"19","author":"Rosen","year":"2006","journal-title":"Mod Pathol"},{"key":"key20180107151056_b22-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2005.10.029","article-title":"The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer","volume":"101","author":"Malander","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180107151056_b23-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1525-1438.2007.00875.x","article-title":"Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40","volume":"17","author":"Domanska","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107151056_b24-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"key20180107151056_b25-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1025700807451","article-title":"Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study","volume":"2","author":"Piek","year":"2003","journal-title":"Fam Cancer"},{"key":"key20180107151056_b26-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10689-005-6573-2","article-title":"Survival of patients with ovarian cancer due to a mismatch repair defect","volume":"4","author":"Crijnen","year":"2005","journal-title":"Fam Cancer"},{"key":"key20180107151056_b27-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1011590617833","article-title":"Cancer risk in mismatch repair gene mutation carriers","volume":"1","author":"Watson","year":"2001","journal-title":"Fam Cancer"},{"key":"key20180107151056_b28-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2009.068130","article-title":"Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds","volume":"47","author":"Grindedal","year":"2010","journal-title":"J Med Genet"},{"key":"key20180107151056_b29-mco-02-06-0909","first-page":"3087","article-title":"Loss of DNA mismatch repair in acquired resistance to cisplatin","volume":"56","author":"Aebi","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107151056_b30-mco-02-06-0909","first-page":"6039","article-title":"Reversal of drug resistance in human tumor xenografts by 2\u2032-deoxy-5-azacytidine-induced demethylation of the hMLHl gene promoter","volume":"60","author":"Plumb","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107151056_b31-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2407-6-201","article-title":"Mismatch repair and treatment resistance in ovarian cancer","volume":"6","author":"Helleman","year":"2006","journal-title":"BMC Cancer"},{"key":"key20180107151056_b32-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"key":"key20180107151056_b33-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/gyno.2000.6065","article-title":"Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance","volume":"80","author":"Brown","year":"2001","journal-title":"Gynecol Oncol"},{"key":"key20180107151056_b34-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910420507","article-title":"Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer","volume":"42","author":"Zurawski","year":"1988","journal-title":"Int J Cancer"},{"key":"key20180107151056_b35-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0090-8258(90)90130-D","article-title":"Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer","volume":"36","author":"Zurawski","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"10 Suppl","key":"key20180107151056_b36-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G","article-title":"Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers","volume":"76","author":"Skates","year":"1995","journal-title":"Cancer"},{"key":"key20180107151056_b37-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107151056_b38-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/bmj.306.6884.1030","article-title":"Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography","volume":"306","author":"Jacobs","year":"1993","journal-title":"BMJ"},{"key":"key20180107151056_b39-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N Eng J Med"},{"issue":"1124","key":"key20180107151056_b40-mco-02-06-0909","first-page":"1126","article-title":"Familial ovarian screening - effective or ineffective?","volume":"95","author":"Jacobs","year":"2006","journal-title":"Br J Cancer"},{"issue":"Suppl 3","key":"key20180107151056_b41-mco-02-06-0909","first-page":"S2","article-title":"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian Screening Trial: Results from 4 years of annual screening in a randomized trial","volume":"104","author":"Partridge","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107151056_b42-mco-02-06-0909","first-page":"997","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2","volume":"227","author":"Burke","year":"1997","journal-title":"Cancer Genetics Studies Consortium JAMA"},{"key":"key20180107151056_b43-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"key":"key20180107151056_b44-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2011.39.7638","article-title":"Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule","volume":"31","author":"Rosenthal","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107151056_b45-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"key20180107151056_b46-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.1983.03330360040033","article-title":"Oral contraceptive use and the risk of endometrial cancer","volume":"249","year":"1983","journal-title":"JAMA"},{"key":"key20180107151056_b47-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"key20180107151056_b48-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"key20180107151056_b49-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/ije\/29.5.799","article-title":"Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer","volume":"29","author":"Tavani","year":"2000","journal-title":"Int J Epidemiol"},{"key":"key20180107151056_b50-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.bjc.6602239","article-title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","volume":"91","author":"Whittemore","year":"2004","journal-title":"Br J Cancer"},{"key":"key20180107151056_b51-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"key":"key20180107151056_b52-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.1997.03540350065035","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"key20180107151056_b53-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/JCO.2005.08.096","article-title":"Surgical prevention of cancer","volume":"23","author":"Bertagnolli","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11 Suppl","key":"key20180107151056_b54-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2457::AID-CNCR2>3.0.CO;2-I","article-title":"Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a model","volume":"86","author":"Lynch","year":"1999","journal-title":"Cancer"},{"key":"key20180107151056_b55-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u2018sentinel cancer\u2019 for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key20180107151056_b56-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107151056_b57-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3892\/ijo.2012.1528","article-title":"Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome (Review)","volume":"41","author":"Banno","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107151056_b58-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.10667","article-title":"Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer","volume":"102","author":"Boks","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180107151056_b59-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000267500.27329.85","article-title":"Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families","volume":"110","author":"Chen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key20180107151056_b60-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180107151056_b61-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180107151056_b62-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/AOG.0b013e3181b6f4f9","article-title":"Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome","volume":"115","author":"Schmeler","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4 Suppl","key":"key20180107151056_b63-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U","article-title":"Role of heredity in multiple primary cancer","volume":"40","author":"Lynch","year":"1977","journal-title":"Cancer"},{"key":"key20180107151056_b64-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000167394.38215.56","article-title":"Ovarian conservation at the time of hysterectomy for benign disease","volume":"106","author":"Parker","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key20180107151056_b65-mco-02-06-0909","first-page":"2596","article-title":"Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas","volume":"133","author":"Niskakoski","year":"2013","journal-title":"Int J Cancer"},{"key":"key20180107151056_b66-mco-02-06-0909","first-page":"1084","article-title":"Targeting Ras-PI3K\/mTOR pathway and predictive biomarkers in endometrial cancer","volume":"38","author":"Oda","year":"2011","journal-title":"Gan To Kagaku Ryoho"},{"key":"key20180107151056_b67-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","article-title":"Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas","volume":"4","author":"Costa-Guda","year":"2013","journal-title":"Horm Cancer"},{"key":"key20180107151056_b68-mco-02-06-0909","first-page":"5698","article-title":"Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma","volume":"56","author":"J\u00fcrgens","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107151056_b69-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jmg.2004.020651","article-title":"BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing","volume":"41","author":"Domingo","year":"2004","journal-title":"J Med Genet"},{"key":"key20180107151056_b70-mco-02-06-0909","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1158\/1078-0432.CCR-10-2315","article-title":"Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS\/CTCF expression ratio and advanced stage","volume":"17","author":"Woloszynska-Read","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.397\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T10:11:13Z","timestamp":1515319873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,20]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,8,20]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/mco.2014.397"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.397","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,20]]}}}